Parkinsonโ€™s Disease Research Insights from Dr. J. Timothy Greenamyre

Shaping the Future of Parkinsonโ€™s Treatment: Dr. Greenamyreโ€™s Contributions and Outlook The American Parkinson Disease Association (APDA) is committed...see more to furthering Parkinsonโ€™s disease (PD) research and proudly invests in the most promising clinicians and scientific projects focused on the discovery of the cause(s) and finding the cure(s) for PD. Our Centers for Advanced Research, along with […]

Read More

How AI is Revolutionizing Parkinsonโ€™s Research and Clinical Care

Understanding AI: A Powerful Tool in the Fight Against Parkinsonโ€™s Disease Artificial Intelligence (AI) is all around us and...see more becoming more and more ubiquitous in many aspects of our lives, including Parkinsonโ€™s disease (PD) research and clinical care. But what exactly is AI, and how is it accelerating PD research and improving how doctors care […]

Read More

New Parkinsonโ€™s Disease Treatments in the Clinical Trial Pipeline

Promising New Treatments for Parkinsonโ€™s: Whatโ€™s in the Clinical Trial Pipeline? There remains an urgent unmet need for Parkinsonโ€™s...see more disease (PD) treatments that slow or halt the underlying neurodegenerative process that leads to disease progression. Much research is focused on this, with clinical trials underway. It is also critical that medications continue to be developed […]

Read More

Understanding the Different Forms of Carbidopa/Levodopa: Additional Questions Answered

Exploring the New Forms of Carbidopa/Levodopa with Dr. Vaou On a recent episode of APDAโ€™s Dr. Gilbert Hosts, I spoke with...see more Dr. Okeanis Vaou, a movement disorders specialist, about the various new formulations of carbidopa/levodopa that are available, including Crexontยฎ and Vyalevยฎ, among others.   Carbidopa/levodopa is the mainstay of treatment for Parkinsonโ€™s disease (PD) and is […]

Read More

The History of the American Parkinson Disease Association

The American Parkinson Disease Association (APDA) has long been committed to providing the support, education, research, and community that...see more helps everyone impacted by Parkinsonโ€™s disease (PD) live life to the fullest โ€“ a legacy that dates back to APDAโ€™s founding in 1961, when a young woman named Sophia Esposito Maestrone sought to honor the memory […]

Read More

Women & PD Research Progress: Catching Up with APDA Researcher Dr. Roberta Marongiu

Advancing Parkinsonโ€™s Disease Research: APDAโ€™s Commitment to Innovation The American Parkinson Disease Association (APDA) is committed to furthering Parkinsonโ€™s...see more disease (PD) research and proudly invests in the most promising clinicians and scientific projects focused on the discovery of the cause(s) and finding the cure(s) for PD. Our Centers for Advanced Research, along with a variety of […]

Read More

Parkinsonโ€™s Disease and the Loss of Independence: Coping Strategies & Support

Navigating Independence with Parkinsonโ€™s Disease As a progressive neurodegenerative movement disorder, Parkinsonโ€™s disease (PD) comes hand in hand with...see more an increasing loss of independence as the disease advances, resulting in a gradual loss of independence. This is often difficult to navigate and can sometimes contribute further to the depression and anxiety that many people experience […]

Read More

Can exercise slow down Parkinsonโ€™s progression? The SPARX3 trial investigates

The SPARX3 Research Trial Investigates How Exercise Helps Parkinsonโ€™s People with Parkinsonโ€™s disease (PD) are constantly being told, by...see more family, friends, doctors and the APDA community, that exercise is a vital part of any Parkinsonโ€™s treatment plan and is essential to functioning at your best with PD. To support this claim, there are many clinical […]

Read More

Tracking the Impact: 2024 APDA-funded Parkinsonโ€™s Research

APDA proudly invests in the most promising clinicians and scientific projects focused on the discovery of the cause(s) and...see more finding the cure(s) for Parkinsonโ€™s disease (PD). APDA is committed to scientific research and has been a funding partner in many major scientific breakthroughs related to Parkinsonโ€™s disease, investing more than $62 million in research since […]

Read More